Immunology
Showing page 141 of 176 pages of list content
-
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes in COVID-19 convalescent plasma
This article's authors -
Preclinical study of DNA vaccines targeting SARS-CoV-2
This article's authors -
Tobacco, but not nicotine and flavor-less electronic cigarettes, induces ACE2 and immune dysregulation
This article's authors -
COVID-19 genetic risk variants are associated with expression of multiple genes in diverse immune cell types
This article's authors -
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases
This article's authors -
Critical Interactions Between the SARS-CoV-2 Spike Glycoprotein and the Human ACE2 Receptor
This article's authors -
PRAK-03202: A triple antigen VLP vaccine candidate against SARS CoV-2
This article's authors -
Hydroxyzine inhibits SARS-CoV-2 Spike protein binding to ACE2 in a qualitative in vitro assay
This article's authors -
Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class
This article's authors -
A key linear epitope for a potent neutralizing antibody to SARS-CoV-2 S-RBD
This article's authors